Abstract: Provided are crystalline forms of fexofenadine hydrochloride and processes for their preparation.

Abstract: Provided are novel crystalline forms of valacyclovir hydrochloride denominated forms VIII, IX, X, XI, and XII and methods of making them. Also provided is a novel method for making valacyclovir hydrochloride in crystalline form V.

Abstract: This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.

Abstract: A system and method for data management according to the content of the data. The present invention enables data to be stored in one of a plurality of different storage options according to at least one characteristic of the data, in which the at least one characteristic is related to the content of the data. The present invention comprises a rule-based storage management mechanism for the processes of archiving and/or retrieving data. It should be noted that at least one storage option according to the present invention is optionally deletion and/or destruction of the data, such that the data may optionally be removed from storage media or may optionally not be stored initially on the storage media. Optionally and more preferably, the data is stored for a time interval according to the at least one characteristic of the data. Most preferably, the data is moved to a different type of storage option after an event occurs, for example the time interval has elapsed.

Abstract: Provided is a method of improving the flowability of losartan potassium powder having an initial Hausner ratio of 1.45 or more, which method includes reslurrying the losatrtan potassium in a reslurry solvent.

Abstract: This invention relates to a novel crystalline solid of carvedilol or a solvate thereof, to processes for its preparation, to compositions containing it and to its use in medicine. This invention further relates to a novel process for preparing a crystalline solid of carvedilol Form II.

Abstract: A system and method for data management according to the content of the data. The present invention enables data to be stored in one of a plurality of different storage options according to at least one characteristic of the data, in which the at least one characteristic is related to the content of the data. The present invention comprises a rule-based storage management mechanism for the processes of archiving and/or retrieving data. It should be noted that at least one storage option according to the present invention is optionally deletion and/or destruction of the data, such that the data may optionally be removed from storage media or may optionally not be stored initially on the storage media. Optionally and more preferably, the data is stored for a time interval according to the at least one characteristic of the data. Most preferably, the data is moved to a different type of storage option after an event occurs, for example the time interval has elapsed.

Abstract: This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.

Abstract: This invention relates to a novel crystalline solid of carvedilol or a solvate thereof, to processes for its preparation, to compositions containing it and to its use in medicine. This invention further relates to a novel process for preparing a crystalline solid of carvedilol Form II.

Abstract: This invention relates to a novel crystalline solid of carvedilol or a solvate thereof, to processes for its preparation, to compositions containing it and to its use in medicine. This invention further relates to a novel process for preparing a crystalline solid of carvedilol Form II.

Abstract: This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.